INHIBITORY EFFECT OF 5-HYDROXY-4-(2-PHENYL-(E)-ETHENYL)-2(5H)-FURANONE, A NOVEL SYNTHESIZED RETINOID, ON AZOXYMETHANE-INDUCED INTESTINAL CARCINOGENESIS IN RATS

被引:23
作者
MORI, H
YOSHIMI, N
SUGIE, S
TANAKA, T
MORISHITA, Y
JINLONG, G
TAMAI, Y
TORIHARA, M
YAMAHARA, J
机构
[1] KURARAY CO LTD, OSAKA, JAPAN
[2] MORISHITA JINTAN CO LTD, OSAKA, JAPAN
关键词
RETINOID; CHEMOPREVENTION; AZOXYMETHANE; INTESTINE; RAT;
D O I
10.1016/0304-3835(92)90220-P
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Modifying effects of 5-hydroxy-4-(2-phenyl-(E)ethenyl)-2(5H)-furanone, a novel synthesized retinoid (KYN-54), on intestinal carcinogenesis were examined in a rat model using azoxymethane (AOM). A total of ninety male F344 rats, 6 weeks old, were divided into 4 groups. Group 1 (20 rats) was fed a diet containing KYN-54 at a concentration of 0.02% for 3 weeks, during which time 2 s.c. injections of azoxymethane (15 mg/kg) were applied and then kept on a basal diet until the end of the experiment (1 year). Group 2 (30 rats) was given azoxymethane as in group 1 and fed the basal diet throughout, without synthetic retinoid exposure. Group 3 (20 rats) was administered KYN-54 at the commencement of the experiment, but not given the carcinogen. Group 4 (20 rats) received a basal diet alone throughout the experiment and served as a control. Intestinal tumors were seen in groups 1 and 2, their incidence and average number in group 1 (74%, 1.07 +/- 0.87) being significantly less than in group 2 (39%, 0.56 +/- 0.78) (P < 0.02 and P < 0.05, respectively). These results suggest that the synthetic retinoid might be a promising chemopreventive agent for intestinal neoplasia.
引用
收藏
页码:93 / 98
页数:6
相关论文
共 19 条
[1]  
BERTRAM JS, 1987, CANCER RES, V47, P3012
[2]  
BOONE CW, 1990, CANCER RES, V50, P2
[3]  
BURING JE, 1990, IARC SCI PUBL, V103, P185
[5]   INHIBITORY EFFECT OF CHLOROGENIC ACID ON METHYLAZOXYMETHANOL ACETATE-INDUCED CARCINOGENESIS IN LARGE-INTESTINE AND LIVER OF HAMSTERS [J].
MORI, H ;
TANAKA, T ;
SHIMA, H ;
ASU, TK ;
TAKAHASHI, M .
CANCER LETTERS, 1986, 30 (01) :49-54
[6]  
NARISAWA T, 1981, CANCER RES, V41, P1954
[7]  
NISHINO H, 1991, Journal of Kyoto Prefectural University of Medicine, V100, P831
[8]  
REDDY BS, 1981, JNCI-J NATL CANCER I, V66, P553
[9]  
REDDY BS, 1988, CANCER RES, V48, P6642
[10]  
REDDY BS, 1988, CANCER RES, V48, P1777